|
Scientific Programme |
|
Thursday, 24 February 2011 |
| 10.30-10.35 |
Opening remarks |
|
Lisa Licitra (ESMO)
Vincent Grégoire (ESTRO)
Jean-Louis Lefebvre (EHNS) |
| 10.35-11.15 |
Keynote lecture: Don’t forget the HPV negative patients! |
|
Kian Ang (USA) |
| 11.15-12.00 |
Late breaking data from randomised trials |
|
ARCON FOR T2-T4 LARYNGEAL CANCER: RESULTS OF A PHASE III RANDOMIZED TRIAL
J. Kaanders (NL)
COMORBIDITY AMONG 13,651 HEAD AND NECK CANCER PATIENTS FROM THE DAHANCA-DATABASE
C. Boeje (DK)
TAXANE-CISPLATIN-5FU AS INDUCTION CHEMOTHERAPY IN LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA: AN INDIVIDUAL PATIENT DATA META-ANALYSIS OF THE MACH-NC GROUP
P. Blanchard (FR) |
| 12.00-14.00 |
Lunch and Industry Symposium |
| 14.00-15.30 |
Symposium 1: Thyroid Cancer |
| |
Extent of Thyroidectomy for Papillary Thyroid Cancer. Will the controversy ever end?
Marc Hamoir (Belgium)
Minimal invasive surgery
Paolo Miccoli (Italy)
Targeted therapy in refractory thyroid cancer
Martin Schlumberger (France) |
| 15.30-16.00 |
Coffee and Networking Break |
| 16.00-18.00 |
Proffered papers |
|
NARROW BAND IMAGING AND HIGH DEFINITION TELEVISION IN DIAGNOSIS AND SURVEILLANCE OF HEAD AND NECK CANCER
C. Piazza (IT)
PROGNOSTIC VALUES OF TUMOR BLOOD FLOW, [18F]EF5 AND [18F]FDG PET/CT IMAGING IN PATIENTS WITH HEAD AND NECK CANCER
G. Komar (FI)
MULTI-CENTER VALIDATION OF A LYMPH NODE METASTASIS GENE-EXPRESSION SIGNATURE FOR HEAD AND NECK SQUAMOUS CELL CARCINOMAS
R. Takes (NL)
HYPOXIC GENE EXPRESSION WITH PROGNOSTIC AND PREDICTIVE IMPACT FOR HYPOXIC MODIFICATION IN HEAD AND NECK CANCER
K. Toustrup (DK)
LOCALLY ADVANCED NASAL CAVITY AND ETHMOID CARCINOMA: INDUCTION CHEMOTHERAPY FOLLOWED BY MULTIMODAL TREATMENT IN A MONOINSTITUTIONAL SERIES OF PATIENTS
P. Bossi (IT)
EXCELLENT IDENTICAL OUTCOMES FOR RADIATION ALONE VS CHEMORADIATION IN MINIMAL SMOKING HPV(+) N0-N2C OROPHARYNX CANCER PATIENTS
B. O'Sullivan (CA)
IS P16 IMMUNOHISTOCHEMISTRY A SURROGATE FOR THE PRESENCE OF AN HPV INFECTION IN HEAD AND NECK SQUAMOUS CELL CARCINOMA?
B. Weynand (BE)
P16 IMMUNOHISTOCHEMISTRY AND HPV-PCR FOR RESPONSE PREDICTION AFTER RADIOTHERAPY IN HNSCC
E. Van Limbergen (BE)
DISCUSSANT and Q&A |
| 18.00-20.00 |
Welcome reception |
| |
Friday, 25 February 2011 |
| 08.30-10.10 |
Symposium 2: Computer aided and Image guided treatments |
| |
Recent imaging developments
Robert Hermans (Belgium)
Image guided RT for H&N Cancer
Coen Rasch (The Netherlands)
Robotic Head & Neck Surgery and the Role of Minimally Invasive Surgery within Multidisciplinary Care
Speaker: Christopher Holsinger (USA)
Discussant: Jochen Werner (Germany)
Molecular imaging
Stefano Fanti (IT) |
| 10.10-10.40 |
Coffee and Networking Break |
| 10.40-12.00 |
Proffered papers |
|
SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY IN DENMARK 2004-2008 - A NATIONWIDE STUDY FROM DAHANCA
C. Grau (DK)
QUALITY OF LIFE AND FUNCTIONAL STATUS IN HEAD AND NECK CANCER PATIENTS: DOES QUALITY OF LIFE PREDICT LONG-TERM SURVIVAL?
A. Tarsitano (IT)
THE BEHAVIOUR OF ELDERLY PATIENTS TREATED WITH CHEMORADIATION. A SINGLE INSTITUTION EXPERIENCE
M. Merlano (IT)
FACTORS ASSOCIATED WITH ACUTE AND LATE DYSPHAGIA IN THE DAHANCA 6 & 7 TRIAL
HR. Mortensen (DK)
PREDICTIVE MODELS FOR DYSPHAGIA AFTER (CHEMO)RADIATION IN HEAD AND NECK CANCER: A MULTICENTER PROSPECTIVE COHORT STUDY
M. Christianen (NL)
A PREDICTIVE MODEL FOR FEEDING TUBE DEPENDENCY AFTER CURATIVE RADIOTHERAPY OR CHEMORADIATION IN HEAD AND NECK CANCER
H. Langendijk (NL)
DISCUSSANT and Q&A |
| 12.00-14.00 |
Lunch and Industry Symposium |
|
14.00-15.40 |
Symposium 3: Should we treat all locally advanced H&N cancer patients in the same way? |
|
State of the art in the treatment of oral cavity tumors
Hisham Mehanna (United Kingdom)
State of the art in the treatment of oropharynx tumor
Cai Grau (Denmark)
State of the art in the treatment of larynx tumors
Joël Guigay (France) |
| 15.40-16.10 |
Coffee and Networking Break |
| 16.10-17.10 |
Symposium 4: Evidence-based medicine or practice-based medicine? |
|
Case presentation
Jean-Louis Lefebvre (FR)
French Survey on EBM versus PBM
Jean-Louis Lefebvre (FR)
Value based cancer care
Arlene Forastière (USA) |
| 17.10-19.10 |
Industry Symposium |
|
Saturday, 26 February 2011 |
| 08.30-10.10 |
Symposium 5: Global care of patients (social concern, family, cultural issues, psychosocial support, what do patients expect, treatment of acute and late toxicities) |
|
New thoughts on treatment related mucositis in Head and Neck cancer patients
Nathaniel Treister (USA)
Morbidity after surgical treatment
SN Rogers (United Kingdom)
Acute and late radiation-induced swallowing dysfunction in head and neck radiotherapy
Hans Langendijk (The Netherlands)
The view point of the advocacy group on patient management
Melanie Brooks (UK) |
| 10:10-10:40 |
Coffee and Networking Break |
| 10.40-12.00 |
Symposium 6: Metastatic /recurrent disease |
|
Re-irradiation
Eric Lartigau (France)
Surgical Salvage for Head and Neck Tumors after Chemoradiation Failure
C. René Leemans (The Netherlands)
Chemotherapy/targeted agents (state of the art today)
Jean-Pascal Machiels (Belgium)
What’s new in medical treatment (new and future drugs and concept)?
Chris Boshoff (United Kingdom) |
| 12.00-13.00 |
Symposium 7: Sinonasal and base of skull tumours |
|
Limits of endoscopic surgery for sinonasal malignancies
Piero Nicolai (Italy)
Hadrontherapy for sinonasal malignancies and skull base tumors
Carmen Ares (Switzerland)
Treatment approaches of non squamous cell sinonasal malignancies
Lisa Licitra (Italy) |
| 13.00 |
End of the meeting |
|
Last updated 19 November 2010 |